![DISRxUPT artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts114/v4/cb/98/86/cb98860b-852a-b39c-ecf7-7060493985ac/mza_9370682438625692185.jpg/100x100bb.jpg)
Episode 17 | Advancing Compounding Technology - Joe D'Silva and Will Boyko
DISRxUPT
English - April 15, 2022 09:00 - 51 minutes - 117 MBLife Sciences Science Business Entrepreneurship pharmacy innovation healthcare medication higher education college university education cedarville ohio Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Joe D'Silva, founder, CEO, and CSO of Patient & Consumers (P&C) Pharma, has always had an eye toward developing high-quality pharmaceutical products. Driven by a passion for enhancing personalized patient care and a vision to take the technology used in the pharmaceutical industry into the pharmacy itself, Joe left roles in the pharmaceutical industry to found P&C Pharma. Through this work, Joe developed QuartetRx, a first-in-class oral liquid compounding device that leverages wet milling technology to produce consistent oral liquid medications without the need for manual compounding. In this episode of DISRxUPT, Will Boyko, consultant pharmacist with P&C Pharma, along with Joe D'Silva, join us to discuss their journey of taking QuartetRx from a dream to a reality and the ways in which this technology can benefit both patients and pharmacists. We will also discuss how current and future pharmacists can be change agents in the profession.